Glaucoma Therapeutics Market Size Projected to Reach USD 13.

Pharmacological actions of several ophthalmic medications are directed against glaucoma. In order to treat glaucoma, a few more recent drug classes assist in increasing aqueous fluid outflow and lower intraocular pressure.Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global glaucoma therapeutics market was projected to attain US$ 8.3 billion in 2022. It is anticipated to garner a 5.5% CAGR from 2023 to 2031 and by 2031, the market

Related Keywords

Delaware , United States , Canada , China , America , Americans , Nikhil Alani , Asia Pacific , Aerie Pharmaceuticals , Alembic Pharmaceuticals , National Diabetes Statistics , Merck Co , Transparency Market Research Inc , Abbvie Inc , Transparency Market Research , Drug Administration , Surgical Centers , Glaucoma Research Foundation , Santen Pharmaceutical Co , Pfizer Inc , Centers For Disease , Bausch Health Companies Inc , Market Research , National Diabetes Statistics Report , Disease Control , United States Food , Brimonidine Tartrate Ophthalmic Solution , Glaucoma Therapeutics , North America , Its Related Factors , Glaucoma Therapeutics Market , More Reports , Chocolate Market , Extract Market , Canada Toll Free , Global Market , Intraocular Pressure , Research And Development , Wilmington , Research , Glaucoma , Market Expansion ,